Prot #PTI-808-01: A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PTI-808 in Healthy Adult Subjects and in Adults with Cystic Fibrosis

Project: Research project

Project Details

StatusActive
Effective start/end date8/2/188/2/21

Funding

  • Chiltern International, Inc. (Prot #PTI-808-01)
  • Proteostasis Therapeutics, Inc. (Prot #PTI-808-01)